Business
Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO
Vaxxas HD-MAP Self Administration Vaxxas HD-MAP Self Administration Vaxxas CEO David Peacock Vaxxas CEO David Peacock Vaxxas HD-MAP Vaxxas HD-MAP BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive Officer to lead the commercialisation of the Company’s proprietary high‑density microarray patch (HD‑MAP) vaccination technology. Mr Peacock brings more than
About this update from Medical Developments International Limited
[{"type":"image","alt":"Vaxxas Pty Ltd","displaySize":"","headline":null,"caption":"Vaxxas Pty Ltd","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":62,"url":"https://media.zenfs.com/en/globenewswire.com/011fe35b68e2d1c8fac9267c8cd82958"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/J9SKMERr.sHQWqvL9Z5vtg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/011fe35b68e2d1c8fac9267c8cd82958","width":300,"height":62}},"lazy":false},{"type":"text","content":"Vaxxas HD-MAP Self Administration","length":33,"tagName":"p"},{"type":"image","alt":"Vaxxas HD-MAP Self Administration","displaySize":"","headline":null,"caption":"Vaxxas HD-MAP Self Administration","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1900,"height":1267,"url":"https://media.zenfs.com/en/globenewswire.com/47fdab02acd87a5ed923ded1e50903f9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5ASmg0uKiJ33LgAdxzukaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/47fdab02acd87a5ed923ded1e50903f9","width":960,"height":640},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/VzEUwc5fGDe_KS4gGM6b4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xNjAwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/47fdab02acd87a5ed923ded1e50903f9","width":1200,"height":800}}},{"type":"text","content":"Vaxxas CEO David Peacock","length":24,"tagName":"p"},{"type":"image","alt":"Vaxxas CEO David Peacock","displaySize":"","headline":null,"caption":"Vaxxas CEO David Peacock","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":4948,"height":3280,"url":"https://media.zenfs.com/en/globenewswire.com/de933d97b81b1687f876bcde56ba16b0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ILqTum.uOmGwZhAcMMh0ag--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTYzNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/de933d97b81b1687f876bcde56ba16b0","width":960,"height":636},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/OUcyTgkP16ScEuog7DCkMQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xNTkwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/de933d97b81b1687f876bcde56ba16b0","width":1200,"height":795}}},{"type":"text","content":"Vaxxas HD-MAP","length":13,"tagName":"p"},{"type":"image","alt":"Vaxxas HD-...
More updates from Medical Developments International Limited